Insider · CIK 0001771680
YAO TONY DUNG LING
Reports to the SEC for 2 companies · DURHAM, NC
Transactions
17
Companies
2
Filings
4
CIK
0001771680
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2020-12-15 | FDMT4D Molecular Therapeutics, Inc.C Conversion | — |
| 2020-12-15 | FDMT4D Molecular Therapeutics, Inc.C Conversion | — |
| 2020-12-15 | FDMT4D Molecular Therapeutics, Inc.C Conversion | — |
| 2020-12-15 | FDMT4D Molecular Therapeutics, Inc.P Purchase | +$9.78M |
| 2020-12-15 | FDMT4D Molecular Therapeutics, Inc. · Series B Preferred StockC Conversion | — |
| 2020-12-15 | FDMT4D Molecular Therapeutics, Inc. · Series B Preferred StockC Conversion | — |
| 2020-12-15 | FDMT4D Molecular Therapeutics, Inc. · Series C Preferred StockC Conversion | — |
| 2019-04-03 | DTILPRECISION BIOSCIENCES INCP Purchase | +$100K |
| 2019-04-01 | DTILPRECISION BIOSCIENCES INCC Conversion | — |
| 2019-04-01 | DTILPRECISION BIOSCIENCES INCC Conversion | +$502K |
| 2019-04-01 | DTILPRECISION BIOSCIENCES INCC Conversion | — |
| 2019-04-01 | DTILPRECISION BIOSCIENCES INCC Conversion | — |
| 2019-04-01 | DTILPRECISION BIOSCIENCES INC · Series B Preferred StockC Conversion | — |
| 2019-04-01 | DTILPRECISION BIOSCIENCES INC · Convertible Promissory NoteC Conversion | — |
| 2019-04-01 | DTILPRECISION BIOSCIENCES INC · Series B Preferred StockC Conversion | — |
| 2019-04-01 | DTILPRECISION BIOSCIENCES INC · Series B Preferred StockC Conversion | — |
| 2019-03-27 | DTILPRECISION BIOSCIENCES INC · Convertible Promissory NoteJ Other | — |
Recent filings
- 4YAO TONY DUNG LING0001567619-20-021287SEC(opens sec.gov)
- 4YAO TONY DUNG LING0001209191-19-023673SEC(opens sec.gov)
- 4YAO TONY DUNG LING0001209191-19-022659SEC(opens sec.gov)
- 4YAO TONY DUNG LING0001209191-19-021849SEC(opens sec.gov)
Companies
Address
C/O PRECISION BIOSCIENCES, INC. 302 E. PETTIGREW STREET, SUITE A-100
DURHAM, NC, 27701